Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00783471 · TERMINATED

Trial details

NCT number: NCT00783471
Sponsor: Hellenic Cooperative Oncology Group
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Non-Small Cell Lung Cancer

Start date: 2008-11-01
Primary completion: 2010-05-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.